Ignite Creation Date:
2024-05-06 @ 7:27 AM
Last Modification Date:
2024-10-26 @ 11:48 AM
Study NCT ID:
NCT02535221
Status:
RECRUITING
Last Update Posted:
2021-11-29
First Post:
2015-06-09
Brief Title:
Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER HER2- Breast Cancer
Sponsor:
Peking University
Organization:
Peking University
Organization Data
Organization:
Peking University
Class:
OTHER
Study ID:
BCP12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University
Lead Sponsor Class:
OTHER
Responsible Party:
Tao OUYANG
Responsible Party Title:
Chairman of Breast Center of Peking University Cancer Hospital
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Peking University
Old Name:
None
Old Organization:
None